Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3728897
Max Phase: Preclinical
Molecular Formula: C10H20O
Molecular Weight: 156.27
Molecule Type: Small molecule
Associated Items:
ID: ALA3728897
Max Phase: Preclinical
Molecular Formula: C10H20O
Molecular Weight: 156.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H]1CC[C@@H](CO)CC1
Standard InChI: InChI=1S/C10H20O/c1-8(2)10-5-3-9(7-11)4-6-10/h8-11H,3-7H2,1-2H3/t9-,10+
Standard InChI Key: KHWTYGFHPHRQMP-AOOOYVTPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 156.27 | Molecular Weight (Monoisotopic): 156.1514 | AlogP: 2.44 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.61 | CX LogD: 2.61 |
Aromatic Rings: 0 | Heavy Atoms: 11 | QED Weighted: 0.65 | Np Likeness Score: 0.70 |
1. (2013) Agent for inhibiting odor of pyrazine derivatives, |
Source(1):